23.72

5.19% 1.17

Elanco Animal Health Inc (ELAN)

Overview News Price History Option Chain Financials Discussions Forecast

Elanco Animal Health Inc stock is traded at $23.72, with a volume of 2.01M. It is up +5.19% in the last 24 hours and up +3.13% over the past month. Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.

Previous Close:

$22.55

Open:

$22.83

24h Volume:

2.01M

Relative Volume:

0.43

Market Cap:

$11.85B

Revenue:

$4.89B

Net Income/Loss:

$-242.00M

P/E Ratio:

-48.51

EPS:

-0.489

Net Cash Flow:

$315.00M

1W Performance:

+5.24%

1M Performance:

+3.13%

6M Performance:

+2.11%

1Y Performance:

+15.65%

1-Day Range:

$22.80

$23.72

1-Week Range:

$22.22

$22.98

52-Week Range:

$19.40

$27.98

Elanco Animal Health Inc Stock (ELAN) Company Profile

Name

Elanco Animal Health Inc

Sector

Healthcare (1051)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

877-352-6261

Address

450 ELANCO CIRCLE, INDIANAPOLIS

Employee

9,900

Twitter

@Elanco

Next Earnings Date

2026-11-06

Latest SEC Filings

ELAN's Discussions on Twitter

Compare ELAN vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ELAN Elanco Animal Health Inc	23.72	11.85B	4.89B	-242.00M	315.00M	-0.489
TAK Takeda Pharmaceutical Co Adr	19.63	62.71B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	41.25	48.11B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.965	43.82B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	78.69	32.51B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	548.81	23.54B	3.17B	1.29B	1.01B	27.09

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-15-26	Initiated	Citigroup	Buy
Jan-22-26	Upgrade	Piper Sandler	Neutral → Overweight
Dec-09-25	Initiated	Barclays	Overweight
Nov-21-25	Initiated	KeyBanc Capital Markets	Overweight
Nov-19-25	Upgrade	Argus	Hold → Buy
Oct-07-25	Upgrade	JP Morgan	Neutral → Overweight
Jul-17-25	Upgrade	Leerink Partners	Market Perform → Outperform
Jun-26-25	Upgrade	William Blair	Mkt Perform → Outperform
Dec-09-24	Initiated	UBS	Buy
Dec-02-24	Initiated	Leerink Partners	Market Perform
Sep-19-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-05-24	Upgrade	Stifel	Hold → Buy
Dec-19-23	Initiated	Jefferies	Buy
Dec-15-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Dec-07-23	Initiated	Exane BNP Paribas	Outperform
Apr-20-23	Upgrade	Barclays	Equal Weight → Overweight
Aug-18-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-16-22	Downgrade	JP Morgan	Overweight → Neutral
Jul-21-22	Downgrade	Goldman	Buy → Sell
Jul-12-22	Initiated	Piper Sandler	Neutral
Nov-18-21	Initiated	Morgan Stanley	Overweight
Oct-28-21	Downgrade	Stifel	Buy → Hold
Aug-05-21	Resumed	Credit Suisse	Outperform
Jun-15-21	Upgrade	Cleveland Research	Underperform → Neutral
May-11-21	Upgrade	Barclays	Underweight → Equal Weight
May-11-21	Upgrade	Gabelli & Co	Hold → Buy
Apr-15-21	Initiated	Stifel	Buy
Mar-22-21	Downgrade	Gabelli & Co	Buy → Hold
Feb-26-21	Upgrade	Credit Suisse	Neutral → Outperform
Dec-09-20	Downgrade	Argus	Buy → Hold
Nov-09-20	Downgrade	Barclays	Overweight → Underweight
Aug-20-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-13-20	Resumed	Credit Suisse	Neutral
Aug-04-20	Resumed	Goldman	Buy
Jul-27-20	Downgrade	Cleveland Research	Neutral → Underperform
Apr-02-20	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-10-20	Initiated	Raymond James	Mkt Perform
Dec-19-19	Upgrade	BofA/Merrill	Neutral → Buy
Nov-07-19	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-23-19	Initiated	Barclays	Overweight
Aug-26-19	Downgrade	BofA/Merrill	Buy → Neutral
Aug-15-19	Upgrade	UBS	Sell → Neutral
May-23-19	Initiated	Guggenheim	Neutral
Mar-18-19	Upgrade	BofA/Merrill	Neutral → Buy
Mar-13-19	Resumed	Morgan Stanley	Equal-Weight
Feb-12-19	Initiated	William Blair	Mkt Perform
Jan-23-19	Initiated	UBS	Sell
Jan-15-19	Initiated	Argus	Buy
Oct-15-18	Initiated	Morgan Stanley	Equal-Weight

View All

Elanco Animal Health Inc Stock (ELAN) Latest News

Oct 01, 2026

Deferring cash fees, Elanco (ELAN) director Kapila K. Anand acquires 642 stock-linked units. - stocktitan.net

Oct 01, 2026

Sep 22, 2026

Elanco Animal Health CEO Jeffrey N. Simmons Reports Acquisition of Deferred Stock Units - Kalkine Media

Sep 22, 2026

Form 4 Elanco Animal Health For: 22 September By Investing.com - Investing.com Nigeria

Sep 22, 2026

Form 4 Elanco Animal Health For: 22 September By Investing.com - Investing.com Canada

Sep 22, 2026

Elanco Animal Health Incorporated (ELAN) Latest Press Releases & Corporate News - finance.yahoo.com

Sep 11, 2026

Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement - Yahoo Finance

Sep 11, 2026

Sep 10, 2026

Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - PR Newswire

Sep 10, 2026

Sep 09, 2026

Elanco Animal Health (ELAN) CFO receives 8 deferred stock units - Stock Titan

Sep 09, 2026

Deferred stock award lifts Elanco Animal Health (NYSE: ELAN) exec's holdings - Stock Titan

Sep 09, 2026

Elanco (NYSE: ELAN) CEO adds to deferred pay with new stock grant - Stock Titan

Sep 09, 2026

Elanco Animal Health (ELAN) 10K Form and Latest SEC Filings 2026 - MarketBeat

Sep 09, 2026

Sep 08, 2026

Mutts With a Mission: How Elanco and Medical Mutts Transform Lives Together - CSRwire

Sep 08, 2026

Sep 04, 2026

Elanco Animal Health Stock Price Forecast. Should You Buy ELAN? - StockInvest.us

Sep 04, 2026

Elanco Director Purchases 40,000 Shares for $936,000 - Yahoo Finance

Sep 04, 2026

Elanco Director Purchases 40,000 Shares for $936,000 - The Motley Fool

Sep 04, 2026